TP53 and breast cancer: The loss of heterozygosity in a few chromosomal regions, or at locations such as p53 at chromosome 17q13 [121], BRCA1 at 17q21 [122] and BRCA2 at 13q12-13 [123], has been shown to influence breast cancer outcome.